Stock Events

Trulieve Cannabis 

$10.48
226
-$0.01-0.11% Today

Statistics

Day High
10.9
Day Low
10.47
52W High
14.5
52W Low
3.42
Volume
188,435
Avg. Volume
530,850
Mkt Cap
1.96B
P/E Ratio
-3.97
Dividend Yield
-
Dividend
-

Earnings

9MayConfirmed
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2023
Q1 2024
-0.61
-0.3
0
0.31
Expected EPS
-0.11
Actual EPS
-0.05

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TCNNF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Curaleaf
CURLF
Mkt Cap3.62B
Curaleaf Holdings, Inc. operates in multiple states offering similar cannabis products, directly competing in several of Trulieve's key markets.
Green Thumb Industries
GTBIF
Mkt Cap2.73B
Green Thumb Industries Inc. has a significant presence in the U.S. cannabis market, offering a range of products that compete with Trulieve's offerings.
Cresco Labs
CRLBF
Mkt Cap703.8M
Cresco Labs Inc. operates across several states with a focus on medicinal and recreational cannabis, directly competing with Trulieve's product lines.
Trulieve Cannabis
TCNNF
Mkt Cap1.96B
TerrAscend Corp. has a growing footprint in the U.S. cannabis market, offering similar products and competing for market share in some of the same states as Trulieve.
Aurora Cannabis
ACB
Mkt Cap402.55M
Aurora Cannabis Inc. is a Canadian company with international operations, competing in the global market for cannabis products, including markets where Trulieve operates.
Canopy Growth
CGC
Mkt Cap913.17M
Canopy Growth Corporation operates in Canada and the U.S., offering products that compete with Trulieve, especially in the CBD and medical cannabis segments.
Tilray Brands
TLRY
Mkt Cap1.53B
Tilray, Inc. has a broad international presence and competes with Trulieve in both the medicinal and recreational cannabis markets, particularly in North America.
Cronos
CRON
Mkt Cap1.11B
Cronos Group Inc. is a global cannabinoid company, competing with Trulieve in the cannabis market through its innovative product lines and international presence.

Analyst Ratings

16.5$Average Price Target
The highest estimate is $19.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

About

Pharmaceuticals: Other
Health Technology
Process Industries
Agricultural Commodities/Milling
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces flower, edible, vaporizer cartridge, concentrate, topical, capsule, tincture, dissolvable powder, and nasal spray products under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands. As of March 16, 2022, it operated 162 dispensaries, which included 113 dispensaries in Florida, 19 affiliated dispensaries in Pennsylvania, 17 dispensaries in Arizona, five dispensaries in California, three dispensaries in Maryland, two dispensaries in Massachusetts, two dispensaries in West Virginia, and one dispensary in Connecticut. Trulieve Cannabis Corp. also operated cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.
Show more...
CEO
Employees
5400
Country
CA
ISIN
CA89788C1041
WKN
000A2N60S

Listings